70 likes | 81 Views
Thereu2019s an exciting development in the treatment of HPV. Until now, there has only been a preventative vaccine that works best when administered before someone becomes sexually active. However, researchers are studying a new immune-based therapy that may be capable of eliminating the virus from tissues in the body after itu2019s already been contracted. https://hpvhub.com/new-hpv-treatment-could-eliminate-cin/
E N D
New HPV Treatment Could Eliminate CIN https://hpvhub.com
There’s an exciting development in the treatment of HPV. Until now, there has only been a preventative vaccine that works best when administeredbefore someone becomes sexually active. However, researchers are studying a new immune-based therapy that may be capable of eliminating the virus from tissues in the body after it’s already been contracted. https://hpvhub.com
Cervical Precancerous Lesions CIN 2 and CIN 3 lesions are always caused by HPV. Previously, the only way to treat CIN 2 and CIN 3 lesions involved removing a cone-shapedpiece of the cervix, sometimes called a LEEP. (1) This procedure shortens the cervix and leads to scarring, which, in turn, can lead to problems getting pregnant, problems during childbirth, and possible miscarriages during the second trimester. (2) Additionally, women who have this procedure have a “very high risk of developing cervical cancer over the next 20 years if they do not continue to be screened.” https://hpvhub.com
Cervical Precancerous Lesions So far, this new type of vaccine has been tested in one study involving women with cervical precancerous lesions resulting from an HPV infection. Cervical precancerous lesions (known as cervical intraepithelial neoplasia or CIN) are separated into three grades of severity: CIN 1 lesions typically clear up on their own. CIN 2 can clear up on their own, but often progress to CIN 3. CIN 3 lesions are the most severe, and less than half of CIN 3 lesions will become cancer within 30 years. https://hpvhub.com
The Study The study consisted of 192 women, all of whom had either CIN 2 or CIN 3 precancerous cervical lesions. Study participants were randomly separated into two groups. The first group was comprised of 129 women who received the therapy and the second group had 63 women who received the placebo. Regardless of group, all of the women received an injection into their thigh once a week for three weeks. Six months after they received their injections, all of the study participants underwent surgery to remove the precancerous cells. https://hpvhub.com
The Results Participants who received the vaccine were twice as likely as those who received the placebo to see their CIN eradicated, regardless of the type of CIN. Additionally, when it came to the more severe stage, somewhere between 15% to 36% of women with CIN 3 saw their CIN completely eliminated, while none of the women with CIN 3 in the placebo group did. Researchers followed these women for three years after receiving the vaccine, and they found that the long-term success was better for those who received the vaccine than those who had the placebo, with more women who had the vaccine remaining completely clear of HPV. Visit for more info: https://hpvhub.com/new-hpv-treatment-could-eliminate-cin/ https://hpvhub.com
Contact - HPV Hub LLC Web - http://hpvhub.com Email - info@hpvhub.com Instagram: https://www.instagram.com/hpvhub/ Facebook: https://www.facebook.com/HPVhub/